1. Home
  2. TRAW

as 04-02-2025 4:00pm EST

$
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

NYSE

Traws Pharma Inc is a biopharmaceutical company focused on developing antivirals for influenza, COVID and other respiratory infections and narazaciclib.

Founded: 1998 Country:
United States
United States
Employees: N/A City: NEWTOWN
Market Cap: 10.1M IPO Year: 2013
Target Price: N/A AVG Volume (30 days): 48.8K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -54674000.00 EPS Growth: N/A
52 Week Low/High: $2.01 - $24.75 Next Earning Date: 03-31-2025
Revenue: $226,000 Revenue Growth: N/A
Revenue Growth (this year): 3.81% Revenue Growth (next year): N/A

TRAW Daily Stock ML Predictions

Share on Social Networks: